Cite
MLA Citation
Martin E. Gore et al.. “Sorafenib dose escalation in treatment‐naïve patients with metastatic renal cell carcinoma: a non‐randomised, open‐label, Phase 2b study.” BJU international, vol. 119, 2017, pp. 846–853. http://access.bl.uk/ark:/81055/vdc_100046455809.0x000003